Explore Henry Schein's Q4 2024 earnings insights, including strategic growth plans, KKR partnership, and financial performance.
Henry Schein has simplified its organizational structure and appointed Andrea Albertini and Tom Popeck to lead its three business groups as part of its 2025 to 2027 BOLD+1 Strategic Plan.
Henry Schein forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation.
Charles R. Goulding and Preeti Sulibhavi explain how KKR’s investment in Henry Schein signals a transformative shift in ...
Reports Q4 revenue $3.19B, consensus $3.25B. “Our fourth quarter financial results reflect relatively stable dental and medical end-markets. We ...
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter and ...
Headquartered in Melville, New York, Henry Schein, Inc. (HSIC) is a global distributor of healthcare products and services, ...
Wells Fargo (NYSE:WFC) initiated coverage of Henry Schein (NASDAQ:HSIC) shares with an Equal-weight rating and a price target of $80.00. The healthcare provider, currently valued at $9.68 billion, has ...
Bain Capital may withdraw tender offer for Fuji Soft, after KKR raised bid in intense bidding war. Global investors target Japan for deals.
KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and ...
KKR posted fourth-quarter net income growth as lower expenses offset a drop in revenue, and assets under management at the buyout firm grew as it prepared for a potential deal bonanza in the second ...